Trial site
University of Wisconsin Clinical Science Center
- 14running trials
- 5closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Cervical cancer3 trials
- Acute myeloid leukaemia2 trials
- Childhood cancers2 trials
- Colorectal cancer2 trials
- Gastric and oesophageal cancer2 trials
- Liver and biliary tract cancer2 trials
- Multiple myeloma2 trials
- Sarcoma2 trials
- Bladder cancer1 trial
- Endometrial cancer1 trial
- Idiopathic pulmonary fibrosis1 trial
- and 6 more
- Phase
- Phase 211 trials
- Phase 33 trials
- Phase 12 trials
- Phase 1/22 trials
- Status
- Active, not recruiting11 trials
- Completed3 trials
- Recruiting3 trials
- Terminated2 trials
- Lead sponsor
- Pfizer3 trials
- Fujifilm Pharmaceuticals U.S.A., Inc.2 trials
- GOG Foundation2 trials
- Seagen, a wholly owned subsidiary of Pfizer2 trials
- Adaptimmune1 trial
- and 9 more
Running trials
Recruiting
Active, not recruiting
A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.
Active, not recruiting
A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer
Recruiting
Active, not recruiting
A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors
Active, not recruiting
Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)
Active, not recruiting
Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Active, not recruiting
Active, not recruiting
Active, not recruiting
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Cervical cancer1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
Closed trials
Terminated
Terminated
Completed
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer
Completed
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026